Trial Profile
Duloxetine versus placebo in the treatment of patients with painful diabetic neuropathy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2006
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 16 Jun 2006 New trial record.